Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation
- PMID: 27080741
- DOI: 10.1016/j.bbabio.2016.04.005
Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation
Abstract
Proteins initially identified as essential for apoptosis also mediate a wide range of non-apoptotic functions that include cell cycle progression, differentiation and metabolism. As this phenomenon was mostly reported with non-cancer cells, we considered non-conventional roles for the apoptotic machinery in the cancer setting. We found that treating glioblastoma (GBM) tumors with siRNA against VDAC1, a mitochondrial protein found at the crossroads of metabolic and survival pathways and involved in apoptosis, inhibited tumor growth while leading to differentiation of tumor cells into neuronal-like cells, as reflected in the expression of specific markers. Although VDAC1 depletion did not induce apoptosis, the expression levels of several pro-apoptotic regulatory proteins were changed. Specifically, VDAC1 deletion led to up-regulation of caspases, p53, cytochrome c, and down-regulation of SMAC/Diablo, AIF and TSPO. The down-regulated group was highly expressed in U-87MG xenografts, as well as in GBMs from human patients. We also showed that the rewired cancer-cell metabolism resulting from VDAC1 depletion reinforced cell growth arrest and differentiation via alterations in the transcription factors p53, c-Myc, HIF-1α and NF-κB. The decrease in c-Myc, HIF-1α and NF-κB levels was in accord with reduced cell proliferation, whereas increased p53 expression promoted differentiation. Thus, upon metabolic re-programing induced by VDAC1 depletion, the levels of pro-apoptotic proteins associated with cell growth decreased, while those connected to cell differentiation increased, converting GBM cells into astrocyte- and neuron-like cells. The results reveal that in tumors, pro-apoptotic proteins can perform non-apoptotic functions, acting as regulators of cell growth and differentiation, making these molecules potential new targets for cancer therapy. This article is part of a Special Issue entitled 'EBEC 2016: 19th European Bioenergetics Conference, Riva del Garda, Italy, July 2-6, 2016', edited by Prof. Paolo Bernardi.
Keywords: Apoptosis; Cell differentiation; Glioblastoma; Metabolism; Mitochondria; VDAC1.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Mitochondria and nucleus cross-talk: Signaling in metabolism, apoptosis, and differentiation, and function in cancer.IUBMB Life. 2021 Mar;73(3):492-510. doi: 10.1002/iub.2407. Epub 2020 Nov 12. IUBMB Life. 2021. PMID: 33179373
-
The mitochondrial voltage-dependent anion channel 1 in tumor cells.Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2547-75. doi: 10.1016/j.bbamem.2014.10.040. Epub 2014 Nov 4. Biochim Biophys Acta. 2015. PMID: 25448878 Review.
-
Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1281-91. doi: 10.1016/j.bbabio.2010.03.003. Epub 2010 Mar 6. Biochim Biophys Acta. 2010. PMID: 20214874
-
VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.Neuro Oncol. 2017 Jul 1;19(7):951-964. doi: 10.1093/neuonc/now297. Neuro Oncol. 2017. PMID: 28339833 Free PMC article.
-
The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.Arch Biochem Biophys. 2015 Aug 15;580:84-92. doi: 10.1016/j.abb.2015.07.005. Epub 2015 Jul 4. Arch Biochem Biophys. 2015. PMID: 26151775 Review.
Cited by
-
Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States.Cancers (Basel). 2018 Dec 8;10(12):499. doi: 10.3390/cancers10120499. Cancers (Basel). 2018. PMID: 30544833 Free PMC article.
-
Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China.Mol Neurodegener. 2018 Jul 6;13(1):36. doi: 10.1186/s13024-018-0269-1. Mol Neurodegener. 2018. PMID: 29980238 Free PMC article.
-
Phosphorylation of cytochrome c at tyrosine 48 finely regulates its binding to the histone chaperone SET/TAF-Iβ in the nucleus.Protein Sci. 2024 Dec;33(12):e5213. doi: 10.1002/pro.5213. Protein Sci. 2024. PMID: 39548742 Free PMC article.
-
Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells.Int J Mol Sci. 2022 Sep 29;23(19):11483. doi: 10.3390/ijms231911483. Int J Mol Sci. 2022. PMID: 36232784 Free PMC article.
-
Metabolic implications of organelle-mitochondria communication.EMBO Rep. 2019 Sep;20(9):e47928. doi: 10.15252/embr.201947928. Epub 2019 Aug 14. EMBO Rep. 2019. PMID: 31418169 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous